Biosimilar Competition: How Might FDA Be Convinced To Change Its Naming Policy?

 
• By Brenda Sandburg
  
Human emotion and mood disorder as a tree shaped as two human faces with one half empty branches the opposite side full of leaves as a medical metaphor for psychological contrast in feelings white
Companies urge FDA to change its mind on biologics naming
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics